# Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea

> **NCT00036192** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 200 (—)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** FK614

## Key facts

- **NCT ID:** NCT00036192
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 200 (—)
- **Last updated:** 2011-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036192, "Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00036192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*